HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathologic study of autosomal dominant vitreoretinochoroidopathy. Peripheral annular pigmentary dystrophy of the retina.

Abstract
Autosomal dominant vitreoretinochoroidopathy (ADVIRC), a recently described disease, is clinically characterized by a slowly progressive or stationary circumferential peripheral pigmentary retinopathy with fibrillar condensation of the vitreous. Histopathologic study of an 88-year-old patient with this disease showed disorganization of the peripheral retina with focally atrophic retinal pigment epithelium (RPE). Altered pigment epithelial cells surrounded retinal blood vessels and lined the internal limiting membrane. At the equator, a remarkable and possibly unique multifocal loss of photoreceptor cells was seen. An extensive preretinal membrane, consisting of condensed vitreous with cellular debris and layers of Müller cells, was demonstrated by electron microscopic examination and immunohistochemistry. Histologically, this entity has some similarities to and some differences from retinitis pigmentosa. The clinical features are distinctive.
AuthorsM F Goldberg, F L Lee, M O Tso, G A Fishman
JournalOphthalmology (Ophthalmology) Vol. 96 Issue 12 Pg. 1736-46 (Dec 1989) ISSN: 0161-6420 [Print] United States
PMID2516300 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Glial Fibrillary Acidic Protein
  • Carbonic Anhydrases
Topics
  • Aged
  • Aged, 80 and over
  • Carbonic Anhydrases (metabolism)
  • Electroretinography
  • Female
  • Fundus Oculi
  • Genes, Dominant
  • Glial Fibrillary Acidic Protein (metabolism)
  • Humans
  • Immunoenzyme Techniques
  • Photoreceptor Cells (ultrastructure)
  • Pigment Epithelium of Eye (ultrastructure)
  • Retina (ultrastructure)
  • Retinal Diseases (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: